Walleye Capital LLC Makes New Investment in Phibro Animal Health Co. (NASDAQ:PAHC)

Walleye Capital LLC purchased a new stake in Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 20,095 shares of the company's stock, valued at approximately $422,000.

Other hedge funds have also recently bought and sold shares of the company. Quantbot Technologies LP raised its stake in Phibro Animal Health by 65.1% in the 4th quarter. Quantbot Technologies LP now owns 5,116 shares of the company's stock worth $107,000 after purchasing an additional 2,018 shares in the last quarter. Meeder Asset Management Inc. acquired a new position in Phibro Animal Health in the 4th quarter valued at $113,000. New York State Teachers Retirement System lifted its position in shares of Phibro Animal Health by 16.7% during the 4th quarter. New York State Teachers Retirement System now owns 5,428 shares of the company's stock valued at $114,000 after acquiring an additional 775 shares during the period. Amundi grew its holdings in shares of Phibro Animal Health by 185.5% during the 4th quarter. Amundi now owns 9,855 shares of the company's stock worth $212,000 after purchasing an additional 6,403 shares in the last quarter. Finally, Envestnet Asset Management Inc. acquired a new position in Phibro Animal Health in the fourth quarter valued at about $219,000. 99.34% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

PAHC has been the subject of a number of research analyst reports. StockNews.com cut Phibro Animal Health from a "buy" rating to a "hold" rating in a report on Tuesday, March 25th. Morgan Stanley set a $20.00 price target on Phibro Animal Health in a report on Tuesday, April 15th. Finally, Barclays increased their price objective on shares of Phibro Animal Health from $20.00 to $22.00 and gave the stock an "underweight" rating in a research report on Monday, February 10th. Two equities research analysts have rated the stock with a sell rating and three have issued a hold rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $19.75.

Phibro Animal Health Stock Up 0.4 %

PAHC stock traded up $0.08 during trading on Tuesday, hitting $18.51. 12,029 shares of the stock traded hands, compared to its average volume of 192,202. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37. Phibro Animal Health Co. has a 1 year low of $13.34 and a 1 year high of $26.55. The stock has a market cap of $749.51 million, a price-to-earnings ratio of 38.52, a price-to-earnings-growth ratio of 0.45 and a beta of 0.63. The firm's 50 day moving average is $20.54 and its two-hundred day moving average is $22.10.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, topping the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. On average, sell-side analysts anticipate that Phibro Animal Health Co. will post 1.95 EPS for the current year.

Phibro Animal Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th were given a dividend of $0.12 per share. The ex-dividend date was Wednesday, March 5th. This represents a $0.48 annualized dividend and a dividend yield of 2.59%. Phibro Animal Health's dividend payout ratio (DPR) is presently 100.00%.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.